357
Views
0
CrossRef citations to date
0
Altmetric
Original research

Impact of Interstitial Lung Abnormalities on Disease Expression and Outcomes in COPD or Emphysema: A Systematic Review

ORCID Icon, &
Pages 189-206 | Received 09 Oct 2022, Accepted 15 Feb 2023, Published online: 02 Mar 2023

References

  • Roth GA, Abate D, Abate KH, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1736–1788. doi:10.1016/S0140-6736(18)32203-7
  • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2022.
  • Pezzuto A, Stellato M, Catania G, et al. Short-term benefit of smoking cessation along with glycopirronium on lung function and respiratory symptoms in mild COPD patients: a retrospective study. J Breath Res. 2018;12(4):46007. doi:10.1088/1752-7163/aad0a8
  • Selman M. The spectrum of smoking-related interstitial lung disorders: the never-ending story of smoke and disease. Chest. 2003;124(4):1185–1187. doi:10.1378/chest.124.4.1185
  • Pezzuto A, Tonini G, Tammaro A, et al. Developed pulmonary fibrosis following COVID-19: a case study. Glob J Respir Care. 2021;7:35–40. doi:10.12974/2312-5470.2021.07.06
  • Cottin V, Selman M, Inoue Y, et al. Syndrome of combined pulmonary fibrosis and emphysema: an official ATS/ERS/JRS/ALAT research statement. Am J Respir Crit Care Med. 2022;206(4):e7–e41. doi:10.1164/rccm.202206-1041ST
  • Washko GR, Hunninghake GM, Fernandez IE, et al. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med. 2011;364(10):897–906. doi:10.1056/NEJMoa1007285
  • Hobbs BD, Putman RK, Araki T, et al. Overlap of genetic risk between interstitial lung abnormalities and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2019;200(11):1402–1413. doi:10.1164/rccm.201903-0511OC
  • Hatabu H, Hunninghake GM, Richeldi L, et al. Interstitial lung abnormalities detected incidentally on CT: a position paper from the Fleischner society. Lancet Respir Med. 2020;8(7):726–737. doi:10.1016/S2213-2600(20)30168-5
  • Washko GR, Lynch DA, Matsuoka S, et al. Identification of early interstitial lung disease in smokers from the COPDGene Study. Acad Radiol. 2010;17(1):48–53. doi:10.1016/j.acra.2009.07.016
  • Hunninghake GM, Hatabu H, Okajima Y, et al. MUC5B promoter polymorphism and interstitial lung abnormalities. N Engl J Med. 2013;368(23):2192–2200. doi:10.1056/NEJMoa1216076
  • Jin GY, Lynch D, Chawla A, et al. Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate. Radiology. 2013;268(2):563–571. doi:10.1148/radiol.13120816
  • Putman RK, Hatabu H, Araki T, et al. Association between interstitial lung abnormalities and all-cause mortality. JAMA. 2016;315(7):672–681. doi:10.1001/jama.2016.0518
  • Araki T, Putman RK, Hatabu H, et al. Development and progression of interstitial lung abnormalities in the Framingham heart study. Am J Respir Crit Care Med. 2016;194(12):1514–1522. doi:10.1164/rccm.201512-2523OC
  • Doyle TJ, Washko GR, Fernandez IE, et al. Interstitial lung abnormalities and reduced exercise capacity. Am J Respir Crit Care Med. 2012;185(7):756–762. doi:10.1164/rccm.201109-1618OC
  • Lee TS, Jin KN, Lee HW, et al. Interstitial lung abnormalities and the clinical course in patients with COPD. Chest. 2021;159(1):128–137. doi:10.1016/j.chest.2020.08.017
  • Ash SY, Harmouche R, Ross JC, et al. Interstitial features at chest CT enhance the deleterious effects of emphysema in the copdgene cohort. Radiology. 2018;288(2):600–609. doi:10.1148/radiol.2018172688
  • Bozzetti F, Paladini I, Rabaiotti E, et al. Are interstitial lung abnormalities associated with COPD? A nested case-control study. Int J Chron Obstruct Pulmon Dis. 2016;11:1087–1096. doi:10.2147/COPD.S103256
  • Ono M, Kobayashi S, Hanagama M, et al. Clinical characteristics of Japanese patients with chronic obstructive pulmonary disease (COPD) with comorbid interstitial lung abnormalities: a cross-sectional study. PLoS One. 2020;15(11):e0239764. doi:10.1371/journal.pone.0239764
  • Ohgiya M, Matsui H, Tamura A, Kato T, Akagawa S, Ohta K. The evaluation of interstitial abnormalities in group B of the 2011 Global Initiative for Chronic Obstructive Lung Disease (GOLD) Classification of Chronic Obstructive Pulmonary Disease (COPD). Intern Med. 2017;56(20):2711–2717. doi:10.2169/internalmedicine.8406-16
  • Chiba S, Tsuchiya K, Nukui Y, et al. Interstitial changes in asthma-COPD overlap syndrome. Clin Respir J. 2017;11(6):1024–1031. doi:10.1111/crj.12461
  • Globle Initiative for Asthma, Globle Initiative for Chronic Obstructive Pulmonary Disease. Diagnosis of Diseases of Chronic Airflow Limitation: Asthma, COPD and Asthma-COPD Overlap Syndrome (ACOS); 2015.
  • Vestbo J, Anderson W, Coxson HO, et al. Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE). Eur Respir J. 2008;31(4):869–873. doi:10.1183/09031936.00111707
  • Regan EA, Hokanson JE, Murphy JR, et al. Genetic epidemiology of COPD (COPDGene) study design. COPD. 2010;7(1):32–43. doi:10.3109/15412550903499522
  • Dawber TR, Meadors GF, Moore FJ. Epidemiological approaches to heart disease: the Framingham study. Am J Public Health Nations Health. 1951;41(3):279–281. doi:10.2105/ajph.41.3.279
  • Harris TB, Launer LJ, Eiriksdottir G, et al. Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics. Am J Epidemiol. 2007;165(9):1076–1087. doi:10.1093/aje/kwk115
  • Menon AA, Putman RK, Sanders JL, et al. Interstitial lung abnormalities, emphysema, and spirometry in smokers. Chest. 2022;161(4):999–1010. doi:10.1016/j.chest.2021.10.034
  • Araki T, Nishino M, Zazueta OE, et al. Paraseptal emphysema: prevalence and distribution on CT and association with interstitial lung abnormalities. Eur J Radiol. 2015;84(7):1413–1418. doi:10.1016/j.ejrad.2015.03.010
  • Hoyer N, Thomsen LH, Wille M, et al. Increased respiratory morbidity in individuals with interstitial lung abnormalities. Bmc Pulm Med. 2020;20(1):67. doi:10.1186/s12890-020-1107-0
  • Wille MM, Dirksen A, Ashraf H, et al. Results of the randomized Danish lung cancer screening trial with focus on high-risk profiling. Am J Respir Crit Care Med. 2016;193(5):542–551. doi:10.1164/rccm.201505-1040OC
  • Kirkham S, Kolsum U, Rousseau K, Singh D, Vestbo J, Thornton DJ. MUC5B is the major mucin in the gel phase of sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;178(10):1033–1039. doi:10.1164/rccm.200803-391OC
  • Tsushima K, Sone S, Yoshikawa S, Yokoyama T, Suzuki T, Kubo K. The radiological patterns of interstitial change at an early phase: over a 4-year follow-up. Respir Med. 2010;104(11):1712–1721. doi:10.1016/j.rmed.2010.05.014
  • Buendia-Roldan I, Fernandez R, Mejia M, et al. Risk factors associated with the development of interstitial lung abnormalities. Eur Respir J. 2021;58(2):2003005. doi:10.1183/13993003.03005-2020
  • Hoyer N, Wille M, Thomsen LH, et al. Interstitial lung abnormalities are associated with increased mortality in smokers. Respir Med. 2018;136:77–82. doi:10.1016/j.rmed.2018.02.001
  • Putman RK, Gudmundsson G, Axelsson GT, et al. Imaging patterns are associated with interstitial lung abnormality progression and mortality. Am J Respir Crit Care Med. 2019;200(2):175–183. doi:10.1164/rccm.201809-1652OC